Use of the muscle volume analyzer to evaluate enzyme replacement therapy in late-onset Pompe disease

被引：4

作者：

Sugai, Fuminobu ^{[1
]}

Kokunai, Yosuke ^{[1
]}

Yamamoto, Yoichi ^{[1
]}

Hashida, Goichi ^{[2
]}

Shimazu, Kengo ^{[2
]}

Mihara, Masahito ^{[1
]}

Inoue, Satoru ^{[2
]}

Sakoda, Saburo ^{[1
]}

机构：

[1] Osaka Univ, Grad Sch Med, Dept Neurol D4, Suita, Osaka 5650871, Japan

[2] Osaka Univ Hosp, Rehabil Unit, Osaka 553, Japan

来源：

JOURNAL OF NEUROLOGY | 2010年 / 257卷 / 03期

关键词：

Pompe disease; Late onset; Muscle volume analyzer; Bioelectric impedance; Handheld dynamometer;

D O I：

10.1007/s00415-009-5367-0

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

The muscle volume analyzer (MVA) can predict limb muscle weight based on bioelectric impedance analysis, whereas the conventional handheld dynamometer (HHD) measures muscle strength. In this study, a 26-year-old female on invasive ventilation due to late-onset Pompe disease was treated with enzyme replacement therapy (ERT) for 12 months. MVA measurements demonstrated time-dependent improvement from the baseline compared to HHD measurements, showing remarkably fluctuating muscle strength. Thus, the MVA can be used as an alternative, particularly for patients suffering from severe limb muscle weakness.

引用

页码：461 / 463

页数：3

共 50 条

[1] Use of the muscle volume analyzer to evaluate enzyme replacement therapy in late-onset Pompe disease
Fuminobu Sugai
Yosuke Kokunai
Yoichi Yamamoto
Goichi Hashida
Kengo Shimazu
Masahito Mihara
Satoru Inoue
Saburo Sakoda
Journal of Neurology, 2010, 257 : 461 - 463
[2] Enzyme replacement therapy for late-onset Pompe disease
Dalmia, Sanjush
Sharma, Reena
Ramaswami, Uma
Hughes, Derralynn
Jahnke, Nikki
Cole, Duncan
Smith, Sherie
Remmington, Tracey
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2023, (12):
[3] Enzyme replacement therapy and antibodies in late-onset Pompe disease
Schneider, I.
Deschauer, M.
Hanisch, F.
MOLECULAR GENETICS AND METABOLISM REPORTS, 2014, 1 : 232 - 234
[4] The impact of interrupting enzyme replacement therapy in late-onset Pompe disease
Stephan Wenninger
Kristina Gutschmidt
Corinna Wirner
Krisztina Einvag
Federica Montagnese
Benedikt Schoser
Journal of Neurology, 2021, 268 : 2943 - 2950
[5] The impact of interrupting enzyme replacement therapy in late-onset Pompe disease
Wenninger, Stephan
Gutschmidt, Kristina
Wirner, Corinna
Einvag, Krisztina
Montagnese, Federica
Schoser, Benedikt
JOURNAL OF NEUROLOGY, 2021, 268 (08) : 2943 - 2950
[6] Enzyme Replacement Therapy in Five Adults with Late-Onset Pompe Disease
Oboudiyat, Carly B.
Pastores, Gregory
Ferraris, Marrisa
Sathe, Swati
NEUROLOGY, 2010, 74 (09) : A519 - A519
[7] Enzyme replacement therapy for late-onset Pompe disease: A systematic review
Domelles, Alicia D.
Kisak, William O. T.
Gertsenchtein, Guilherme I. P. S.
Schwartz, Ida V. D.
MOLECULAR GENETICS AND METABOLISM, 2018, 123 (02) : S40 - S40
[8] Muscle Proteomic Profile before and after Enzyme Replacement Therapy in Late-Onset Pompe Disease
Moriggi, Manuela
Capitanio, Daniele
Torretta, Enrica
Barbacini, Pietro
Bragato, Cinzia
Sartori, Patrizia
Moggio, Maurizio
Maggi, Lorenzo
Mora, Marina
Gelfi, Cecilia
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (06) : 1 - 20
[9] Low-frequency enzyme replacement therapy in late-onset pompe disease
Lin, Dar-Shong
Chiang, Ming-Fu
Ho, Che-Sheng
Hsiao, Chung-Der
Lin, Chang-Yi
Wang, Nien-Lu
Chuang, Chih-Kuang
Huang, Yu-Wen
Chang, Po-Chun
Liu, Hsuan-Liang
MUSCLE & NERVE, 2013, 47 (04) : 612 - 613
[10] Cardiovascular abnormalities in late-onset Pompe disease and response to enzyme replacement therapy
Forsha, Daniel
Li, Jennifer S.
Smith, P. Brian
van der Ploeg, Ans T.
Kishnani, Priya
Pasquali, Sara K.
GENETICS IN MEDICINE, 2011, 13 (07) : 625 - 631

← 1 2 3 4 5 →